Pandemic Preparedness
This article was originally published in Start Up
Executive Summary
Kleiner Perkins Caufield & Byers announced their newest fund for pandemic preparedness Feb 16,2006. The fund's potential to do good is enormous, but skeptics question whether or not it can make money.
You may also be interested in...
Enigma Diagnostics Ltd.
The key to combating an infectious disease threat, be it an individual case of Chlamydia or the global threat of bioterrorism or pandemic avian flu, is rapid on-site diagnosis, enabling physicians to treat--or public health professionals to contain--the disease. One solution is the use of the gold standard test for biological agents, real-time polymerase chain reaction testing. Enigma Diagnostics Ltd. says it is the first UK company to take this technique out of the laboratory and into the field.
Embracing Early-Stage Platform Opportunities at Polaris Ventures
In an interview with START-UP, Polaris Ventures managing partner Terry McGuire discusses recent investment opportunities and his firm's approach to platform technologies in the life sciences. Topics covered include: diagnostics, community diseases, next-generation biologics, and fund diversification.
Embracing Early-Stage Platform Opportunities at Polaris Ventures
In an interview with START-UP, Polaris Ventures managing partner Terry McGuire discusses recent investment opportunities and his firm's approach to platform technologies in the life sciences. Topics covered include: diagnostics, community diseases, next-generation biologics, and fund diversification.